Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2010 Oct;13(10):975-9.
doi: 10.3779/j.issn.1009-3419.2010.10.08.

[Prevention of refractory cough with mediastinal fat to fill the residual cavity after radical systematic mediastinal lymphadenectomy in patients with right lung cancer]

[Article in Chinese]
Jia Huang  1 , Qingquan Luo, Yang Shentu, Xiaojing Zhao
Affiliations
Randomized Controlled Trial

[Prevention of refractory cough with mediastinal fat to fill the residual cavity after radical systematic mediastinal lymphadenectomy in patients with right lung cancer]

[Article in Chinese]
Jia Huang et al. Zhongguo Fei Ai Za Zhi. 2010 Oct.

Abstract
in English, Chinese

Background and objective: The aim of this study is to analyze the impact on the cough after radical systematic mediastinal lymphadenectomy and prevention of refractory cough with mediastinal fat to fill the residual cavity after radical systematic mediastinal lymphadenectomy.

Methods: Sixty patients clinically diagnosed of lung cancer were selected according to the adopt standardization, from January 2008 to December 2008. All of the patients were divided into two groups randomly: the filling-fat group and the non-filling-fat group. The surgical information such as operation duration time bleeding volume during operation, post-operation bleeding volume were recorded. After one month, FACT-L and LCQ were completed.

Results: There are no remarkably differences between the operation duration time, bleeding volume in operation and 1st postoperation day's drainage volume of the two groups. There's significant difference in the scores of cough at night after taking off the chest tube, as well as in the scores of LCQ after one month and in the scores of last items of FACT-L.

Conclusions: Filling the fat of the mediastinal to cover the residual cavity left by completely systematic mediastinal lymphadenectomy can reduce the refractory cough after surgery, and can also improve the quality of the life. It has no effect on the the operation duration time, bleeding volume in operation and 1st post-operation day's drainage volume of the patients.

背景与目的: 肺癌手术系统性清扫淋巴结能一定程度上提高肺癌患者生存率，但也会造成术后并发症增多，例如乳糜胸、喉返神经损伤致声音嘶哑、顽固性咳嗽等。目前国内外尚无外科手术方法改进以减少顽固性咳嗽的发生。本研究旨在探讨前纵隔脂肪填塞残腔是否可减少顽固性咳嗽的发生。

方法: 2008年1月-2008年12月，依纳入标准收治右肺癌患者60例，按随机数字表随机分为使用前纵隔脂肪填塞上纵隔淋巴结清扫遗留的残腔实验组（30例）和未使用前纵隔脂肪填塞上纵隔淋巴结清扫遗留的残腔对照组（30例）。术中依据分组采取不同的方法处理上纵隔淋巴结清扫遗留残腔，记录两组患者术后第1天引流量、拔管时间、住院时间、拔管前后日间和夜间咳嗽评分等具体外科临床资料。分别随访两组患者出院后术后咳嗽情况，并指导患者填写咳嗽量化评分表和FACT-L评分表。

结果: ① 两组患者手术时间、术中失血量、术后第1天胸引量、拔管时间、住院天数无明显差异；②两组患者在拔管前日间、夜间咳嗽及拔管后夜间咳嗽评分无明显差异，在拔管后日间咳嗽评分有统计学差异；③两组患者术后随访咳嗽评分表评分有明显差异；④两组患者FACT-L评分中生理状况、社会/家庭状况、情感状况、功能状况、附加关注五项评分中，后三项评分两组患者有明显差异。

结论: 前纵隔脂肪填塞残腔能有效减少术后顽固性咳嗽的发生，提高患者生存质量。

PubMed Disclaimer

Figures

1
1
处理残腔的具体手术方式。A：不做任何处理；B：用脂肪填塞。 Different surgical handles on the residual cavity left. A: no special treatment; B: using the medialstinal fat to cover the residual cavity.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Wu YL, Wang SY, Huang ZP, et al. Extent of lymphadenectomy in stage Ⅰ-ⅢA non-small cell lung cancer: a randomized clinical trial. http://med.wanfangdata.com.cn/Paper/Detail/PeriodicalPaper_zhzl200101012 Chin J Oncol. 2001;23(1):43–45. - PubMed
    2. 吴 一龙, 王 思愚, 黄 植藩, et al. Ⅰ-ⅢA期非小细胞肺癌淋巴结清扫范围的前瞻性研究. http://med.wanfangdata.com.cn/Paper/Detail/PeriodicalPaper_zhzl200101012 中华肿瘤杂志. 2001;23(1):43–45. - PubMed
    1. Keller S M, Adak S, Wagner H, et al. Mediastinal lymph node dissection improves survival in patients with stage Ⅱ and Ⅲa non-small cell lung cancer. Eastern Cooperative Oncology Group. Ann Thorac Surg. 2000;70(2):358–366. doi: 10.1016/S0003-4975(00)01673-8. - DOI - PubMed
    1. Farray D, Mirkovic N, Albain KS. Multimodality therapy for stage Ⅲ non-small-cell lung cancer. J Clin Oncol. 2005;23(14):3257–3269. doi: 10.1200/JCO.2005.03.008. - DOI - PubMed
    1. Okada M, SakamotoT, Yuki T, et al. Selective mediastinal lymphadenectomy for clinico-surgical stage Ⅰ non-small cell lung cancer. Ann Thorac Surg. 2006;81(3):1028–1032. doi: 10.1016/j.athoracsur.2005.09.078. - DOI - PubMed
    1. Guo CJ, Dong HJ. The Diagnosis and treatment of Cough. http://guide.medlive.cn/guideline/3210 Chin J Postgraduate Med. 2007;30(2):1–3.
    2. 郭 雪君, 董 欢霁. 咳嗽的诊断与治疗. http://guide.medlive.cn/guideline/3210 中国医师进修杂志. 2007;30(2):1–3.

Publication types